Correlation Between Scisparc and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Scisparc and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scisparc and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scisparc and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Scisparc and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scisparc with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scisparc and Sonnet Biotherapeutics.
Diversification Opportunities for Scisparc and Sonnet Biotherapeutics
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scisparc and Sonnet is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Scisparc and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Scisparc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scisparc are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Scisparc i.e., Scisparc and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Scisparc and Sonnet Biotherapeutics
Given the investment horizon of 90 days Scisparc is expected to generate 1.58 times more return on investment than Sonnet Biotherapeutics. However, Scisparc is 1.58 times more volatile than Sonnet Biotherapeutics Holdings. It trades about 0.0 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.54 per unit of risk. If you would invest 23.00 in Scisparc on August 30, 2024 and sell it today you would lose (1.00) from holding Scisparc or give up 4.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scisparc vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Scisparc |
| Sonnet Biotherapeutics |
Scisparc and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scisparc and Sonnet Biotherapeutics
The main advantage of trading using opposite Scisparc and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scisparc position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Scisparc vs. Virax Biolabs Group | Scisparc vs. ZyVersa Therapeutics | Scisparc vs. Unicycive Therapeutics | Scisparc vs. Quoin Pharmaceuticals Ltd |
| Sonnet Biotherapeutics vs. Ikena Oncology | Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. HCW Biologics | Sonnet Biotherapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |